Tempus AI, Inc. (TEM)
Bolsa Mexicana de Valores · Mexico · prices in MXN · close of 27 Oct 2026
Key indicators
| Last close | MXN 1,340.12 |
|---|---|
| 52-week range | 725.00 – 1,713.00 |
| Return, 1 month / 3 months | −11.1% / +78.7% |
| Return, 1 year / 3 years | −21.8% / – |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 73.8% |
| Worst drawdown (1 year) | -57.1% |
| Average daily value traded | 0.69M MXN |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Tempus AI is a healthcare technology company based in Chicago that combines laboratory testing with artificial intelligence. It provides genomic sequencing and molecular testing services that help physicians choose treatments for patients, particularly in cancer care. The company also offers data and analytics products used by healthcare providers, researchers and pharmaceutical companies to study diseases and support clinical decisions. Its work centres on bringing together clinical and molecular information in a single platform.
The shares are listed on the Bolsa Mexicana de Valores in Mexico under the code TEM, and the price on this page is in Mexican pesos (MXN). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Tempus AI, Inc. (TEM) trades on the Bolsa Mexicana de Valores in Mexico. It last closed at MXN 1,340.12 on 27 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 186 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 21.8% and over the last three months it rose 78.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bolsa Mexicana de Valores
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 34.9% | ||
| From 52-week high | -21.8% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 78.7% | ||
| 6-month return | 50.6% | ||
| 12-month return, skipping the last month | -12.0% | ||
| Stability (higher is calmer) | 6 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 73.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -57.1% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.69M MXN | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +6.7% |
|---|---|
| 1 month | −11.1% |
| 3 months | +78.7% |
| 6 months | +50.6% |
| 1 year | −21.8% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 1,229.08 / 993.30 |
|---|---|
| Golden / death cross (60 days) | Golden, 26 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 57.95 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bolsa Mexicana de Valores; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.